Kinins—II pp 603-606 | Cite as

Altered Urinary Excretion of Human Kininase Activity in Acute Myocardial Infarction

  • A. Greco
  • G. Porcelli
  • A. G. Rebuzzi
  • M. Di Jorio
  • M. Ranieri
  • L. Ranalli
Part of the Advances in Experimental Medicine and Biology book series (AEMB)

Abstract

This study concerns the determination of levels of human urinary kininase excretion in acute myocardial infarction (AMI). The results obtained by a biological method show that there is a significant reduction of the enzymatic activity in patients affected by AEI in comparison with normals (6.4 ± 0.4 ng of destroyed bradykinin/min. versus 164.4 ± 31.4 ng; P < 0.001), while urinary kallikrein excretion was close to normal values.

Keywords

Acute Myocardial Infarction Acute Myocardial Infarction Circulatory Shock Essential Hypertensive Patient Urinary Kallikrein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe K. and Seino M. (1975), Urinary kallikrein excretion and sodium metabolism in hypertention, Life Sci., 16, 817CrossRefGoogle Scholar
  2. Adetuyibi A., Mills I.H. (1972), Relationship between urinary kallikrein and renal function, hypertension and excretion of sodium and water in man. Lancet 2, 203PubMedCrossRefGoogle Scholar
  3. Burch G.E., De Pasquale N.P. (1963), Bradykinin, Amer. Heart J., 65, 116Google Scholar
  4. Del Bianco P.L., Curradi C., De saint Pierre C. Nava G., Sicuteri F. (1976) Urinary excretion of kallikrein following myocardial infarction, Adv.Exp.Med. and Biol., 70, 329Google Scholar
  5. Erdös E.G.,Yaug H.Y.T. (1970) Kininase; in: Ddb of ezp.pharomcol., Vol. XXV, Ed. by Erdös E.G., Springer verlag, N.Y. p. 289Google Scholar
  6. Greco A., Porcelli G., Croxatto H.R., Fedeli G., Ghirlanda G. (1974) Ipertensione arteriosa e callicreina urinaria, Min.Meú. 65, 3058Google Scholar
  7. Hashimoto K., Hamamoto H., Tajima N., Kimura E. (1974), Changes in Kïuio system and hemodynamics in acute myocardial infarction — a clinical study — VII World Congress of Cardiology, Buenos AiresGoogle Scholar
  8. Hashimoto K., Wanka J., Kohn R.N., Wilkens B.J., Steger R., Back N. (1976) The vasopeptide kinin system in acute clinical cardiac diseases; Adv.Exp.Med.Boil., 70, 245Google Scholar
  9. Margolius H.S., Geller R., Pisano J.J., Sjoerdsma A.(1071), Altered urinary kallikrein excretion in human hypertension, Lancet 2, 1063Google Scholar
  10. Porcelli G., Di Jorio M., Ranieri M., Danalli L., D’Acquarica L. (1978), Method for measurement of human urinary kininase activityGoogle Scholar
  11. Porcelli G., Marini-Battòlo G.B. (1978), A simplified method to prepare human urinary samples for measurement of kalliktein esterase activity, V Nat.Congress of Ital. Soc. of Clin.Biochem., Rome, October 1978Google Scholar
  12. Sicuteri F., Antonini F.M., Del Bianco P.L., Franchi G.C., Curradi C. (1972) prekallikrein and kallikrein inhibitor in plasma of patients affected by recent myocardial infarction, Adr.mxy.Med. Biol., 21, 445CrossRefGoogle Scholar
  13. Vane J.R. (1969), the release and fate of vasoactive hormones in the circulation, Brit. J, PharmacmI., 35, 209CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1979

Authors and Affiliations

  • A. Greco
    • 1
    • 2
  • G. Porcelli
    • 1
    • 2
  • A. G. Rebuzzi
    • 1
    • 2
  • M. Di Jorio
    • 1
    • 2
  • M. Ranieri
    • 1
    • 2
  • L. Ranalli
    • 1
    • 2
  1. 1.Istituto di Patologia Medica and Istituto di ChimicaFacoltà di MedicinaRomaItaly
  2. 2.Roma and Centro Chimica Recettori del C.N.R.Università Cattolica S. CuoreRomaItaly

Personalised recommendations